²é¿´: 64  |  »Ø¸´: 0

»ù´¡ÉúÎïʵÑéÍâ°

гæ (³õÈëÎÄ̳)

[½»Á÷] ÂöÂçĤÐÂÉúѪ¹Ü¶¯ÎïÄ£Ð͵Ĺ¹½¨

//
¶¯ÎïµÄÑ¡Ôñ


Ö÷ÒªÓÐÊó¡¢ÍúͺïµÈ¡£ÊóÊÇÄ¿Ç°ÓÕµ¼CNVÄ£ÐÍÓ¦ÓÃ×î¹ã·ºµÄʵÑ鶯Îï¡£

Êó

ÊóÓÕµ¼CNVµÄ·¢ÉúÂʽϸߣ¬´óÔ¼ÓÐ60£¥¡«70£¥ÔÚ¹âÄýºó¶Ìʱ¼ä£¨1ÖÜ£©ÄÚ¼´¿É²úÉú£¬¶øÇÒ¹âÄý°ßÓ«¹âÉø©10¡«14Ìì´ïµ½¸ß·å£¬±ãÓÚ½øÐиÉÔ¤ÐÔÑо¿£»ÓÕµ¼CNVµÄÌõ¼þÒ²¿É±ê×¼»¯£¬¼Û¸ñÏà¶Ô±ãÒË£¬±ãÓÚ»ùÒò²Ù×÷£¬¿ÉÓÃÓڹ۲쵥һ»ùÒò¹ý±í´ï»òµÍ±í´ï¶ÔCNVÉú³ÉµÄÓ°Ïì¡£

²»×ãÖ®´¦ÊÇFFAÖй۲쵽µÄÐÂÉúѪ¹ÜÉø©Âʵͣ¬½öΪ28£¥£¬ÇÒÊóµÄÑÛÇò½ÏС£¬²Ù×÷¼¼ÊõÒªÇó¸ß¡£´óÊóºÍСÊóCNVµÄÓÕ·¢ÂÊÎÞÃ÷ÏÔ²îÒ죬СÊóÑÛÇò¸üС£¬²Ù×÷ÒªÇó¸ü¸ß£¬¸üÊÊÓÚ½øÐÐÓйػùÒòÇóý·½ÃæµÄÑо¿¡£

ºï

ʵÑéÐÔºïCNVÄ£ÐÍÓëÈËÀ༲²¡¸Ä±ä¼«ÎªÏàËÆ£¬²»½ö×é֯ѧ¸Ä±äÒ»Ö£¬ÔÚÑÛµ×Ó«¹âËØѪ¹ÜÔìÓ°£¨FFA£©ÖÐÒ²¾ßÓÐÓ«¹âËØÉø©µÄÌØÕ÷¡£ÕâÖÖÐÂÉúѪ¹ÜÒ»°ã·¢ÉúÔÚ¼¤¹â¹âÄýºó4ÖÜ£¬¿É³ÖÐø2¡«52ÖÜ¡£ÔöÉúÒÆÐеÄRPEϸ°û°üÈÆÐÂÉúѪ¹Üºó£¬ÐÂÉúѪ¹ÜÓ«¹âËØÉø©µÄ±íÏÖ»áÔ½À´Ô½²»Ã÷ÏÔ¡£

¾¡¹ÜÕâÖÖÄ£Ð͵õ½ÁËÒ»ÖµÄÈÏ¿É£¬µ«¶¯ÎïÀ´Ô´ÊÜÏÞ£¬·ÑÓýϸߣ¬CNVÓÕ·¢Ê±¼ä½Ï³¤£¬·¢ÉúÂʵͣ¬ÏÞÖÆÁËÆäÓ¦Óá£

ÍÃ

ÍòúÉúµÄCNVÔÚFFAÖв»¾ßÓÐÓ«¹âËØÉø©µÄÌØÕ÷£¬¼ÓÖ®¿¼Âǵ½ÍõÄÑÛµ×Ѫѭ»·½á¹¹ÓëÈËÀàÓнϴóµÄ²îÒ죬ĿǰÒÑ»ù±¾²»ÓÃÍÃ×ö´ËÀàÄ£ÐÍ¡£

//
ÔìÄ£·½·¨


Ò»
¼¤¹âÓÕµ¼¶¯ÎïÄ£ÐÍ

ÔìÄ£·½·¨£º

½¡¿µ×ØɫŲÍþ´óÊó£¬ÐÛÐÔ£¬ÌåÖÊÁ¿180-200g£¬10%Ë®ºÏÂÈÈ©(0.35mL/100gÌåÖÊÁ¿)¸¹Ç»×¢ÉäÂé×í¡£¸´·½ÍÐßÁ¿¨°·µÎÑÛÒºµãÑÛɢͫ¡£ÑÛÇ°·ÅÖõμÓÉÙÁ¿ 1%¼×»ùÏËάËصĸDz£Æ¬½Ó´¥½ÇĤ£¬ë´¼¤¹â(²¨³¤647nm£¬¹â°ßÖ±¾¶50um£¬¹¦ÂÊ360mW£¬Æعâʱ¼ä0.05s)¾àÊÓÅÌ2~3¸öÊÓÅÌÖ±¾¶¾ùÔȹâÄý9¸öµã£¬ÒÔ¼ûµ½ÓÐÆøÅݲúÉúÌáʾBruchĤ±»»÷´©Îª×¼¡£



FFAµÄ¹Û²ì£º

¹âÄýºóµÚ3¡¢7¡¢14¡¢21¡¢30dËæ»úÑ¡È¡4Ö»´óÊóÐÐFFA¼ì²é¡£É¢Í«¼°Âé×í·½·¨Í¬Ç°£¬10%Ó«¹âËØÄÆ×¢ÉäÒº0.5mL/kg¸¹Ç»×¢ÉäºóÁ¢¼´ÐÐFFA¡£FFAͼÏñ·ûºÏÒÔÏÂÌص㼴ÈÏΪCNVÐγɣ¬¢ÙÔÚÔìÓ°ÔçÆÚ¼´¶¯ÂöÇ°ÆÚ»ò¶¯ÂöÆÚ¼´ÏÔÓ°¡£¢ÚÓëÊÓÍøĤѪ¹ÜϵͳûÓÐÁªÏµ¡£¢ÛÓ«¹âËØѸËÙÉø©£¬ÓÐÒ»¶¨µÄ»ý´æ·¶Î§£¬ºóÆÚÐγɸßÓ«¹âÇø¡£½«¸÷ʱ¼ä¶Î³öÏÖCNV¹âÄý°ßÊýÄ¿Óë¸Ãʱ¼ä¶ÎµÄ¹âÄý°ß×ÜÊýµÄ±ÈÖµ×÷Ϊ¸Ãʱ¶ÎµÄCNV·¢ÉúÂÊ¡£

ºóÐø½øÐй⾵¹Û²ì¡¢×éÖ¯²¡ÀíѧCNVÏà¶Ôºñ¶È²âÁ¿¡¢Í¸Éäµç¾µ¹Û²ì¡£



Óŵ㣺

¼¤¹âÓÕµ¼µÄCNV¶¯ÎïÄ£ÐÍ·¢ÉúÂʽϸߣ¬´óԼΪ 60%~70%£¬ÔÚ¹âÄýºó¶ÌÆÚʱ¼ä£¨7d£©ÄÚ¼´¿É²úÉú£¬¶øÇÒ¼¤¹â°ßµÄÓ«¹âËØÉø©ÔÚ 10~14d´ïµ½¸ß·å£¬±ãÓÚ½øÐиÉÔ¤ÐÔÑо¿£»ÓÕµ¼CNVµÄÌõ¼þÒ²¿É±ê×¼»¯£¬¼Û¸ñÏà¶Ô±ãÒË£¬ÊÇÄ¿Ç°ÑÛ¿ÆÓÕµ¼CNV×î³£ÓõĶ¯ÎïÄ£ÐÍ¡£



¶þ
Éú³¤Òò×ÓÓÕµ¼CNVÄ£ÐÍ

°üÀ¨ÊÓÍøĤÏÂ×¢ÉäÔØÓÐѪ¹ÜÄÚƤÉú³¤Òò×Ó£¨vascular endothelial growth factor£¬VEGF£©»ùÒòµÄÏÙÏà¹Ø²¡¶¾ÔØÌå¡¢ÖØ×éVEGFÃ÷½ºÎ¢Á£ÓÕµ¼CNVÄ£ÐÍ¡¢ÊÓÍøĤÏÂ×¢Éä¼îÐÔ³ÉÏËάϸ°ûÉú³¤Òò×Ó£¨basic fibroblastgrowth factor£¬bFGF£©Äý½ºÎ¢Á£ÓÕµ¼ÍÃCNVÄ£ÐÍ¡¢ÊÓÍøĤÏÂ×¢ÉäbFGF/Ö¬¶àÌÇÓÕµ¼ÍÃCNVÄ£ÐÍ¡¢ÂöÂçĤÉÏǻֲÈëbFGF΢Éø͸±ÃÓÕµ¼ÖíCNVÄ£Ð͵ȡ£ÆäÖÐÊÓÍøĤÏÂ×¢ÉäÔØÓÐVEGF»ùÒòµÄÏÙÏà¹Ø²¡¶¾£¨adeno-associated virus£¬AAV£©ÔØÌåÓÕµ¼CNVÄ£ÐÍÊǽÏΪÀíÏëµÄÄ£ÐÍ¡£



ÔìÄ£·½·¨1£º

½«2¦Ìl±àÂëÈË VEGF-A165ÏÙ²¡¶¾×¢Éäµ½´óÊóÊÓÍøĤÏ£¬CNV·¢ÉúÂÊΪ95%¡£



ÔìÄ£·½·¨2£º

ÔÚÍÃÑÛÊÓÍøĤÏÂ×¢Éä5¡Á106IUÔØÓйý±í´ïVEGF-A165ÏÙ²¡¶¾ÔØÌåÓÕµ¼CNVÄ£ÐÍ£¬CNV·¢ÉúÂÊΪ83%¡£



Èý
ת»ùÒò»ò»ùÒòÇóýÓÕµ¼

ת»ùÒòºÍ»ùÒòÇóý½¨Á¢CNVÄ£ÐÍÊÇÒ»ÖÖÐÂÐ˼¼Êõ£¬Õë¶ÔCNV·¢Õ¹µÄ¹Ø¼üÒòËؽ¨Á¢»ùÒò¹¤³ÌÄ£ÐÍ£¬¿É´Ó²»Í¬½Ç¶È·ÖÎö¸÷·Ö×Ó¶ÔCNVÐγɵÄÓ°Ï죬°üÀ¨£º£¨1£©VEGF164RPE65ת»ùÒòСÊ󣻣¨2£©Ë«±¶Ì壨Tet/VMD2/VEGF£©ºÍÈý±¶Ì壨Tet/VMD2/VEGF/An2£©×ª»ùÒòСÊó£¬ÊÓÍøĤ¿É¸ß±í´ïVEGF£¬ÈôͬʱÊÓÍøĤÏÂ×¢ÉäѪ¹ÜÉú³ÉËØ2£¨angiogenin2£¬Ang2£©£¬Äܹ»100%ÐγÉCNV£»£¨3£©Ç÷»¯Òò×ÓCCÀàÊÜÌå2£¨chemokine CC motif receptor 2£¬CCR2£©/Ç÷»¯Òò×ÓCCÀàÅäÌå2£¨chemokine CC motif ligand 2£¬CCL2£©»ùÒòȱʧÓÕµ¼Ð¡ÊóCNVÄ£ÐÍ£¬Æä³ÉÄ£ÂÊ´óÔ¼25£¥£»£¨4£©ÔØÖ¬µ°°×E»ùÒò£¨apolipoprotein E£¬ApoE£©¹ý±í´ïСÊóCNVÄ£ÐÍÊÇÑо¿AMD²¡±äÖÐ×Ô·¢ÐÔCNVÐγɻúÖƵÄÖØҪģÐÍ£»£¨5£©CCL2ºÍCX3CÇ÷»¯Òò×ÓÊÜÌå1£¨CX3C chemokine receptor 1£¬CX3CR1£©»ùÒòȱÏÝСÊ󣻣¨6£©³¬Ñõ»¯ÎïÆ绯ø1£¨superoxide dismutase 1£¬SOD1£©»ùÒòȱÏÝÀÏ»¯Ð¡Ê󣻣¨7£©¼«µÍÃܶÈÖ¬µ°°×ÊÜÌ壨very low density lipoprotein receptor£¬VLDLR£©¶¨ÏòÍ»±äСÊ󣻣¨8£©ÊÓ×ϺìÖÊ»ùÒòÆô¶¯×Ó/VEGF¹ý±í´ïСÊó¡£


ÓÅȱµã£º

ת»ùÒò»ò»ùÒòÇóýÓÕµ¼µÄCNVÄ£Ð;ßÓÐÓÕµ¼¿ì£¬·¢Éúʱ¼ä¶ÌµÈÓŵ㣬ÓëCNV²¡ÀíÉúÀíѧ¹ØÁªÐÔÇ¿£¬¶ÔCNV·¢Éú»úÖƵÄÑо¿¾ßÓÐÕë¶ÔÐÔ£¬Í¬Ê±Ñо¿Õ߿ɸù¾Ý²»Í¬ÐèÇóÑ¡ÔñÄ£ÐͲ¢Ð޸IJÎÊý£»È±µãÓÐCNVÓÕµ¼Âʵ͡¢Ãæ»ýС¡¢¼Û¸ñ¹óµÈÎÊÌâ¡£

//
×ܽá


ÔÚÖڶཨÁ¢CNVÄ£Ð͵ķ½·¨ÖУ¬¼¤¹âÓÕµ¼CNVÄ£ÐÍÌõ¼þ½Ï³ÉÊ죬Ñо¿ÀúÊ·¾Ã£¬¿É¿¿ÐԸߣ¬Ó¦Óù㷺¡£ÓÉÓÚ¶¯ÎïÌåÄÚ»·¾³²»Í¬ÓÚÈËÌåÄÚ»·¾³£¬¸÷ÖÖ·½·¨ÓÕµ¼µÄCNV¶¯ÎïÄ£ÐÍÒ²½öÄÜÄ£ÄâÈËÀàCNV£¬²»ÄÜÍêÈ«´úÌæÈËÀàCNV·¢Õ¹µÄ×ÔÈ»¹ý³Ì£¬Òò´Ë£¬Ñо¿½á¹û½öÄÜΪCNV·¢²¡ºÍ»úÖÆÑо¿ÌṩʵÑéÀíÂÛÒÀ¾Ý¡£
»Ø¸´´ËÂ¥
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌøת ÎÒÒª¶©ÔÄÂ¥Ö÷ »ù´¡ÉúÎïʵÑéÍâ° µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍƼö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[½Ìʦ֮¼Ò] Æß¼¶¸Ú£¬µ½ÊÖ²»µ½8000£¬´ø±¾¿ÆÂÛÎÄ12½Ìѧ·Ö/Éú£¬¶î¶¨½Ìѧ·Ö280 +18 ºÓÎ÷Ò¹ÀÉ 2024-05-02 20/1000 2024-05-03 22:35 by ÃÞ»¨ÌÇww
[ÂÛÎÄͶ¸å] ÏëÇëÎÊÏÂIEEE Trans×îºóÒ»ÂÖ£¬ÄãÃǵÈÁ˶à¾Ã£¿ +3 DD4Dr 2024-05-03 4/200 2024-05-03 20:54 by DD4Dr
[¿¼²©] ²©Ê¿ÉêÇë +6 Farssh 2024-04-29 11/550 2024-05-03 18:05 by ͷͺʳƷ¹·
[ÂÛÎÄͶ¸å] ÏëÎÊϵç³Ø·¢ÔÚnano lettersº¬½ðÁ¿¸ß²»¸ß +4 δÀ´¸»ÆÅÍÜ 2024-04-30 6/300 2024-05-03 16:09 by m739182102
[»ù½ðÉêÇë] ÎåÒ»¼ÙÆÚÆÀÉóÉêÇëÊé +10 zju2000 2024-05-01 14/700 2024-05-03 13:46 by panda_fang
[˶²©¼ÒÔ°] С˶äÉóû¹ý +15 xmc2007 2024-04-28 15/750 2024-05-03 11:23 by ÏþÄ»´Ô
[˶²©¼ÒÔ°] ÕÒ¹¤×÷ǧÍò²»ÄÜÀ´²îѧУ +7 YNÍêµ° 2024-05-02 7/350 2024-05-03 09:27 by shl2112501
[ÂÛÎÄͶ¸å] µÚһƪÂÛÎÄÖÕÓÚ½øÈ¥Éó¸å״̬ÁË +5 lizhengke06 2024-05-01 8/400 2024-05-03 09:14 by nono2009
[¸ß·Ö×Ó] ¸ß·Ö×Ó¾ÛºÏÎïÓлú²ÄÁÏ·½ÏòµÄºÏ×÷/ÕÐƸ¿ÆÑÐÖúÀí +3 wwwzg 2024-05-01 3/150 2024-05-02 21:38 by Dr. Zhang
[˶²©¼ÒÔ°] ²©Ê¿ºóºÍ¿ÆÑÐÖúÀíºÃÄÑÕÒ°¡ +12 ÕÒ¹¤×÷°¡ 2024-04-28 12/600 2024-05-02 16:31 by xysxm
[»ù½ðÉêÇë] ¶à´óËã´óÁ䣿 +4 wyjecho666 2024-05-01 5/250 2024-05-02 13:47 by AD_com
[ÂÛÎÄͶ¸å] Éó¸åÈËÆÀÉóÍê³É״̬»¹ÊÇunder review 5+3 ZH0826 2024-04-30 9/450 2024-05-02 13:13 by ZH0826
[ÂÛÎÄͶ¸å] ÇóÖú£¬ÂÛÎÄСÐÞ·µÐÞÒÔºóScholarOneÉó¸åϵͳ ״̬ 20+5 15546226191 2024-04-30 9/450 2024-05-02 12:28 by ca0yan9
[Óлú½»Á÷] DMFÔõô³ýË® +5 °®³ÔÏã²ËµÄС»Æ¹ 2024-05-01 10/500 2024-05-02 08:27 by kang1386
[½Ìʦ֮¼Ò] Ò»°ã·¢Ê²Ã´ÎÄÕ²ÅÄÜÖÐÇà»ù°¡ +7 ±£³Ö¼¡·ô 2024-04-29 7/350 2024-05-01 17:03 by zju2000
[˶²©¼ÒÔ°] ´ó¼ÒÄܲ»ÄܸøµãÒâ¼û°¡ +4 ÊÇСÂìÒÏÀ² 2024-05-01 11/550 2024-05-01 16:18 by ÊÇСÂìÒÏÀ²
[»ù½ðÉêÇë] µÚ¶þ´ÎÉêÇëÇà»ù£¬×£×Ô¼ººÃÔË! ÖÐ! ÖÐ! ÖÐ! +13 °¢ºÀv5 2024-04-29 15/750 2024-05-01 14:44 by Howard28
[¿¼²©] »ªÄÏÀí¹¤´óѧδÀ´¼¼ÊõѧԺÁÖÕòºê½ÌÊÚ¡°ÄÜÔ´Óë̼¾ö²ß¡±¿ÎÌâ×éÕÐÊÕ2024¼¶²©Ê¿Éú +3 Áõ¼Òç²13 2024-04-28 3/150 2024-05-01 01:37 by ÃÎÏëÑо¿Éú
[¿¼²©] ÉêÇë25Ä격ʿ£¬ÇóÍƼöѧУ¼°²©µ¼ +4 Ã÷¿ªÒ¹ºÏ20 2024-04-28 7/350 2024-04-30 14:23 by Ã÷¿ªÒ¹ºÏ20
[ÕÒ¹¤×÷] ½­ËÕÀí¹¤Ñ§ÔºÒªÉ÷Ñ¡ +8 jjchenshui 2024-04-27 10/500 2024-04-30 10:29 by °ëÉúÃξý
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û